Participant flow18

How many started, completed or left each group, period by period.

1 to 18 of 18

Period	Milestone	Group	Participants
Open-Label Phase	STARTED	LTG: Open-Label Phase	298
Open-Label Phase	STARTED	Placebo	0
Open-Label Phase	STARTED	Lamotrigine	0
Open-Label Phase	COMPLETED	LTG: Open-Label Phase	173
Open-Label Phase	COMPLETED	Placebo	0
Open-Label Phase	COMPLETED	Lamotrigine	0
Open-Label Phase	NOT COMPLETED	LTG: Open-Label Phase	125
Open-Label Phase	NOT COMPLETED	Placebo	0
Open-Label Phase	NOT COMPLETED	Lamotrigine	0
Randomized Phase	STARTED	LTG: Open-Label Phase	0
Randomized Phase	STARTED	Placebo	86
Randomized Phase	STARTED	Lamotrigine	87
Randomized Phase	COMPLETED	LTG: Open-Label Phase	0
Randomized Phase	COMPLETED	Placebo	21
Randomized Phase	COMPLETED	Lamotrigine	20
Randomized Phase	NOT COMPLETED	LTG: Open-Label Phase	0
Randomized Phase	NOT COMPLETED	Placebo	65
Randomized Phase	NOT COMPLETED	Lamotrigine	67

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00723450/flow